[Clinical experiences with avacan in urological diseases].
D002317:Cardiovascular Agents; D005998:Glycine / Q000031:analogs & derivatives; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D014570:Urologic Diseases
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; C004644:camylofine; D005998:Glycine
MUSCLE RELAXANTS/therapeutic use; URINARY TRACT/diseases
Klinische Erfahrungen mit Avacan bei urologischen Erkrankungen.